Genetrump is an industry-leading enterprise focused on the development of active natural polysaccharide molecules. Rooted in Macau and actively integrating into the development of the Greater Bay Area, Genetrump is a technology-driven biotechnology company dedicated to developing China's own high-performance polysaccharide products by combining advanced formulation techniques with unique active natural polysaccharide molecules.

Core Business & Technology:

The company specializes in the extraction, processing, purification, modification, and production of natural polysaccharides. Its core technology aims to break the foreign technological monopoly in polysaccharide extraction and functional modification, establishing an independent polysaccharide processing platform for China. The company's key research areas include:

Structure-Activity Relationship (SAR) Studies: In-depth research into the relationship between the structure and efficacy of (poly/oligo) glucomannan and its derivatives.

Design of Immunoactive Biomaterials: Designing biomaterials with immunomodulatory functions based on polysaccharide molecules.

Cell Therapy Strategies: Engineering novel regenerative cells and testing treatment strategies based on biomaterials or cells in various disease models (e.g., bone defects, limb ischemia, and diabetic skin ulcers).